Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Zenso
AddedFeb 18, 2024
UpdatedJun 18, 2026
Zenso

Zenso

Zenso Labs, a Massachusetts-based medical tech firm, innovatively repurposes brewery waste into high-value products.

HQ
East Weymouth station, MA, US
Founded
2023
Overview
Compare
Fundraising
Employees
Website

Zenso Labs, founded in East Weymouth, Massachusetts, is a pioneering medical tech firm dedicated to transforming waste from breweries and distilleries into high-value products and ingredients. Their core mission is to leverage production biology to create sustainable solutions for beverage producers, including those making hard seltzer, canned cocktails, and low- or no-alcohol beer. By focusing on reducing grain input and waste streams, Zenso Labs aims to revolutionize the industry with eco-friendly practices.

Notable affiliated individuals include Russ, who had the initial epiphany about repurposing organic waste while working at a California vineyard. Zenso Labs collaborates with visionary beverage producers to implement their innovative solutions. Key achievements include the development of their first consumer product, set to launch later this year. The overall impact of Zenso Labs lies in its potential to significantly reduce waste in the beverage industry, promoting sustainability and environmental responsibility.

Zenso - Similar Companies

Jyzen logo

Jyzen

jyzen.com

Zense logo

Zense

zense-life.com

Zen Blend Farms logo

Zen Blend Farms

Zenomics logo

Zenomics

ZestBio logo

ZestBio

zestbio.com

K-Zen Beverage logo

K-Zen Beverage

kzenbeverages.com

Netzro SBC logo

Netzro SBC

netzro.us

Zymosense logo

Zymosense

zymosense.com

Zena Therapeutics logo

Zena Therapeutics

ZenZui logo

ZenZui

Zenwa logo

Zenwa

zenwa.net

Sustainable Beverage Technologies logo

Sustainable Beverage Technologies

Zymeron logo

Zymeron

zymeron.com

Zeno logo

Zeno

ZBiotics logo

ZBiotics

zbiotics.com

Zenso - Quick Facts

Who are Zenso's competitors?

Companies similar to Zenso include Jyzen, Zense, Zen Blend Farms and Zenomics.

When was Zenso founded?

Zenso was founded in 2023.

Where is Zenso's headquarters located?

Zenso's headquarters is located in East Weymouth station, MA, US.

When was Zenso's last funding round?

Zenso's most recent funding round was for $350k (USD) in May 2023.

How much has Zenso raised to-date?

As of May 1, 2023, Zenso has raised a total of $350k (USD).

How many employees does Zenso have?

Zenso has 5 employees as of Feb 4, 2024.

Zenso - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Ingredients
  • Products
Tags
  • Cleantech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified